How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/prevention-of-cerebral-thrombosis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Prevention of Cerebral Thrombosis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention of Cerebral Thrombosis (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of Cerebral Thrombosis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Iopidine	APRACLONIDINE	Harrow Health	alpha-Adrenergic Agonist	Alpha-2A adrenergic receptor	1987-01-01
Persantine	DIPYRIDAMOLE	Boehringer Ingelheim	Platelet Aggregation Inhibitor [EPC]	Equilibrative nucleoside transporter 1	1961-01-01
Dicuman	dicoumarol	AbbVie	dicoumarol	NAD(P)H dehydrogenase [quinone] 1	1944-01-01
Persantin	Persantin	Boehringer Ingelheim		Equilibrative nucleoside transporter 4, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Boehringer Ingelheim · 2 drugs in Prevention of Cerebral Thrombosis
· 1 drug in Prevention of Cerebral Thrombosis
AbbVie · 1 drug in Prevention of Cerebral Thrombosis
Harrow Health · 1 drug in Prevention of Cerebral Thrombosis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of Cerebral Thrombosis:

Cite this brief

Drug Landscape (2026). Prevention of Cerebral Thrombosis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-cerebral-thrombosis. Accessed 2026-06-10.

Prevention of Cerebral Thrombosis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing